Company profile
Circagene Ltd
DNA Genetic Testing with privacy
Genetic Testing for Prevention. #DigitalHealth DNA Genetic Test based on 99.9% of DNA. WORLD'S FIRST INCOGNITO TEST.
Company events
Reference milestones and recent Companies House filing stream events.
Resolution
ResolutionRESOLUTIONS | Transaction WURBMkYyM0VhZGlxemtjeA | Paper/PDF filed
Published 29 Aug 2024 07:00
Liquidation Voluntary Statement Of Affairs
InsolvencyLIQ02 | Transaction MzQzMzExOTQwNWFkaXF6a2N4 | Paper/PDF filed
Published 29 Aug 2024 07:00
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzQzMzExOTAzM2FkaXF6a2N4 | Paper/PDF filed
Published 29 Aug 2024 07:00
Liquidation Voluntary Appointment Of Liquidator
Insolvency600 | Transaction MzQzMzExOTAzNGFkaXF6a2N4 | Paper/PDF filed
Published 29 Aug 2024 07:00
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
An innovative molecular-diagnostic tool using saliva to diagnose and predict risk for periodontal diseases quickly and accurately.
1 Jul 2022 to 30 Jun 2023
CircaGene Ltd is a UK-based _in_**_-_**_vitro_ medical device SME with a core project team of Dr Joanna Wiecek, project lead and microbiome expert, Francois Paillier, bioinformatician and sequencing expert and Jacky Palma, project manager. CircaGene is seeking funding to develop diagnostic software that uses saliva to evaluate oral health and detect perio...